Skip to Main Content

COVID-19 Studies

RESOLUTION
Study of LAU-7b for the Treatment of COVID-19 Disease in Adults
Principal Investigator: Brian Tiffany, MD, PhD

https://clinicaltrials.gov/ct2/show/NCT04417257?term=resolution&cond=covid&draw=2&rank=2

For questions, please call 480-728-4425.


ACTIV-4 (NECTAR)- Novel Experimental COVID-19 Therapies Affection Host Response
Study to find effective strategies for inpatient management of patients with COVID-19. 
Principal Investigator: Brian Tiffany, MD, PhD

https://clinicaltrials.gov/ct2/show/NCT04924660?term=ACTIV-4&recrs=a&draw=2&rank=3

For questions please call: 480-601-5411


ACTIV-6: COVID-19 study of Repurposed Medications
Study to evaluate the effectiveness of repurposed medications in reducing symptoms of non-hospitalized participants with mild to moderate COVID-19. 
Principal Investigator: Brian Tiffany, MD, PhD

https://clinicaltrials.gov/ct2/show/NCT04885530?term=ACTIV-6&draw=2&rank=1

For questions please call: 480-601-5411


Nasal Swab collection for COVID-19 and flu A & B testing
This study aims to collect nasal swab samples from subjects with confirmed positive rapid test for COVID-19, flu A or flu B and subjects presenting with symptoms of those. Samples collected will be used for diagnostic research, product development and validation.
Principal Investigator: Brian Tiffany, MD, PhD

For questions please call: 480-601-5411


ExoFlow Phase III Stem Cell Derived Extracellular Vesicles for COVID-19
Trial to evaluate the efficacy fo ExoFlo in treating moderate to severe ARDS (Acute Respiratory Distress Syndrome) caused by COVID-19
Principal Investigator: Kristopher Roach, MD

https://clinicaltrials.gov/ct2/show/NCT05354141?term=exoflo&recrs=a&cond=COVID-19&draw=2&rank=1

For questions please call: 480-601-5411


Expanded Access Protocol for Stem Cell Derived Extracellular Vesicles for COVID-19
An expanded access protocol intended to provide ExoFlo to critically ill patients who do not qualify for the Phase III randomized control trial. 
Principal Investigator: Kristopher Roach, MD

https://clinicaltrials.gov/ct2/show/NCT04657458?term=exoflo+expanded+access&cond=COVID-19&draw=2&rank=1

For questions please call: 480-601-5411